![](https://healthpolicy.usc.edu/wp-content/uploads/2021/01/Jeet-Headshot-480x480.jpeg)
Recent Work
-
Without Reform, Medicare Policies Will Hamstring New Gene Therapies
It took until the fall of 2020 – three years after FDA approval – for Medicare to consistently pay an adequate amount for CAR-T therapy.
Categorized in
It took until the fall of 2020 – three years after FDA approval – for Medicare to consistently pay an adequate amount for CAR-T therapy.